<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1103" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1103/" /><meta name="ncbi_pagename" content="Primary Trimethylaminuria - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Primary Trimethylaminuria - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Primary Trimethylaminuria" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/10/01" /><meta name="citation_author" content="Ian R Phillips" /><meta name="citation_author" content="Elizabeth A Shephard" /><meta name="citation_pmid" content="20301282" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1103/" /><meta name="citation_keywords" content="Fish Odor Syndrome" /><meta name="citation_keywords" content="FMO3 Deficiency" /><meta name="citation_keywords" content="TMAU" /><meta name="citation_keywords" content="TMAuria" /><meta name="citation_keywords" content="Fish Odor Syndrome" /><meta name="citation_keywords" content="TMAuria" /><meta name="citation_keywords" content="TMAU" /><meta name="citation_keywords" content="FMO3 Deficiency" /><meta name="citation_keywords" content="Dimethylaniline monooxygenase [N-oxide-forming] 3" /><meta name="citation_keywords" content="FMO3" /><meta name="citation_keywords" content="Primary Trimethylaminuria" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Primary Trimethylaminuria" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ian R Phillips" /><meta name="DC.Contributor" content="Elizabeth A Shephard" /><meta name="DC.Date" content="2015/10/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1103/" /><meta name="description" content="Primary trimethylaminuria is characterized by a fishy odor resembling that of rotten or decaying fish that results from excess excretion of trimethylamine in the urine, breath, sweat, and reproductive fluids. No physical symptoms are associated with trimethylaminuria. Affected individuals appear normal and healthy; however, the unpleasant odor often results in social and psychological problems. Symptoms are usually present from birth and may worsen during puberty. In females, symptoms are more severe just before and during menstruation, after taking oral contraceptives, and around the time of menopause." /><meta name="og:title" content="Primary Trimethylaminuria" /><meta name="og:type" content="book" /><meta name="og:description" content="Primary trimethylaminuria is characterized by a fishy odor resembling that of rotten or decaying fish that results from excess excretion of trimethylamine in the urine, breath, sweat, and reproductive fluids. No physical symptoms are associated with trimethylaminuria. Affected individuals appear normal and healthy; however, the unpleasant odor often results in social and psychological problems. Symptoms are usually present from birth and may worsen during puberty. In females, symptoms are more severe just before and during menstruation, after taking oral contraceptives, and around the time of menopause." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1103/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/trimethylaminuria/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1103/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C6712E03F69610000000008A102E3.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1103_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1103_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ph3/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lafora/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1103_"><span class="title" itemprop="name">Primary Trimethylaminuria</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Fish Odor Syndrome, FMO3 Deficiency, TMAU, TMAuria</div><p class="contrib-group"><span itemprop="author">Ian R Phillips</span>, PhD and <span itemprop="author">Elizabeth A Shephard</span>, MSc, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1103_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1103_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ian R Phillips</span>, PhD<div class="affiliation small">Emeritus Professor of Molecular Biology<br />School of Biological and Chemical Sciences<br />Queen Mary, University of London<br />Visiting Professor, Division of Biosciences<br />University College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lumq@spillihp.r.i" class="oemail">ku.ca.lumq@spillihp.r.i</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ku.ca.lcu@spillihp.r.i" class="oemail">ku.ca.lcu@spillihp.r.i</a><div></div></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Elizabeth A Shephard</span>, MSc, PhD<div class="affiliation small">Professor of Molecular Biology <br />Department of Structural and Molecular Biology<br />University College London <br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@drahpehs.e" class="oemail">ku.ca.lcu@drahpehs.e</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 8, 2007</span>; Last Update: <span itemprop="dateModified">October 1, 2015</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="trimethylaminuria.Summary" itemprop="description"><h2 id="_trimethylaminuria_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Primary trimethylaminuria is characterized by a fishy odor resembling that of rotten or decaying fish that results from excess excretion of trimethylamine in the urine, breath, sweat, and reproductive fluids. No physical symptoms are associated with trimethylaminuria. Affected individuals appear normal and healthy; however, the unpleasant odor often results in social and psychological problems. Symptoms are usually present from birth and may worsen during puberty. In females, symptoms are more severe just before and during menstruation, after taking oral contraceptives, and around the time of menopause.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of primary trimethylaminuria is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who:</p><ul><li class="half_rhythm"><div>Excretes (under normal dietary conditions) in the urine &#x0003e;10% of total trimethylamine (TMA) as the free amine; and</div></li><li class="half_rhythm"><div>Has <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> (<a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>), known <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants in <i>FMO3</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><p>Dietary restriction of:</p><ul><li class="half_rhythm"><div>Trimethylamine (present in milk obtained from wheat-fed cows) and its precursors including choline (present in eggs, liver, kidney, peas, beans, peanuts, soya products, and brassicas [Brussels sprouts, broccoli, cabbage, cauliflower]), lecithin and lecithin-containing fish oil supplements;</div></li><li class="half_rhythm"><div>Trimethylamine <i>N</i>-oxide (present in seafood [fish, cephalopods, and crustaceans]);</div></li><li class="half_rhythm"><div>Inhibitors of FMO3 enzyme activity such as indoles (found in brassicas).</div></li></ul><p>Use of:</p><ul><li class="half_rhythm"><div>Acid soaps and body lotions to remove secreted trimethylamine by washing;</div></li><li class="half_rhythm"><div>Activated charcoal and copper chlorophyllin to sequester trimethylamine produced in the gut;</div></li><li class="half_rhythm"><div>Antibiotics (metronidazole, amoxicillin, and neomycin) to suppress production of trimethylamine by reducing bacteria in the gut;</div></li><li class="half_rhythm"><div>Riboflavin supplements to enhance residual FMO3 enzyme activity.</div></li></ul><p><i>Prevention of secondary complications</i>: Planning and monitoring of diet to ensure that the daily intake of choline and folate meets recommendations for age and sex; no restriction of dietary choline during pregnancy and lactation.</p><p><i>Agents/circumstances to avoid</i>: Foods with a high content of precursors of trimethylamine or inhibitors of FMO3 enzyme activity (seafoods: fish, cephalopods, and crustaceans), eggs, offal, legumes, brassicas, and soya products; food supplements and "health" foods that contain high doses of choline and lecithin; drugs metabolized by the FMO3 enzyme; circumstances that promote sweating (e.g., exercise, stress, emotional upsets).</p><p><i>Evaluation of relatives at risk</i>: Biochemical testing of sibs to identify those who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and will benefit from management to reduce production of trimethylamine.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Primary trimethylaminuria is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes and therefore carry one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Heterozygotes (carriers) are asymptomatic. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible once the <i>FMO3</i> pathogenic variants have been identified in the family.</p></div></div><div id="trimethylaminuria.Diagnosis"><h2 id="_trimethylaminuria_Diagnosis_">Diagnosis</h2><p>Diagnosis of primary trimethylaminuria has been discussed in detail [<a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al 2003</a>] and "best-practice" diagnostic guidelines have been summarized [<a class="bk_pop" href="#trimethylaminuria.REF.chalmers.2006">Chalmers et al 2006</a>].</p><div id="trimethylaminuria.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Primary trimethylaminuria <b>should be suspected</b> in individuals with a body odor resembling that of rotten or decaying fish [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mackay.2011.33">Mackay et al 2011</a>] and excessive urinary excretion of trimethylamine (TMA).</p><p><b>Body odor.</b> Unoxidized trimethylamine excreted in the urine, breath, sweat, and reproductive fluids is highly volatile and has a pungent ammoniac odor reminiscent of rotting fish [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mackay.2011.33">Mackay et al 2011</a>].</p><p>Note: Diagnosis of primary trimethylaminuria cannot be based on the examiner&#x02019;s sense of smell due to the following:</p><ul><li class="half_rhythm"><div>The presence of the odor is often episodic and thus may not be noticeable when the person is examined.</div></li><li class="half_rhythm"><div>The human nose is normally very sensitive to trimethylamine, with some individuals being able to detect concentrations as low as 1 part in 10<sup>9</sup>; however, olfactory testing is subjective and some people are unable to detect the smell of trimethylamine.</div></li><li class="half_rhythm"><div>The odor may be caused by compounds other than trimethylamine.</div></li></ul><p><b>Urinary excretion of trimethylamine (TMA).</b> Individuals complaining of or exhibiting a fishy odor should be tested for urinary excretion of TMA, ideally on two separate occasions [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>]. Although testing can be done under normal dietary conditions, it may help to consume a meal rich in choline (e.g., 2 eggs + 400 g "baked" [haricot] or soya beans) prior to testing.</p><p>Note: Because unaffected women may have transient trimethylaminuria at the onset of and during menstruation [<a class="bk_pop" href="#trimethylaminuria.REF.shimizu.2007.2">Shimizu et al 2007</a>], females should not be tested during this time frame.</p><p>Urinary excretion of TMA is measured as <b>one</b> of the following:</p><ul><li class="half_rhythm"><div><b>Percent of total trimethylamine</b> (TMA) (i.e., free TMA plus the non-odorous metabolite TMA <i>N</i>-oxide) excreted in the urine as unmetabolized free TMA [<a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al 2003</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mackay.2011.33">Mackay et al 2011</a>]</div><ul><li class="half_rhythm"><div>Severe trimethylaminuria: &#x0003e;40% of total TMA excreted as unmetabolized free TMA</div></li><li class="half_rhythm"><div>Mild trimethylaminuria: 10%-39% of total TMA excreted as unmetabolized free TMA</div></li><li class="half_rhythm"><div>Unaffected: 0%-9% of total TMA excreted as unmetabolized free TMA</div></li></ul></li><li class="half_rhythm"><div><b>Concentration of unmetabolized TMA in the urine.</b> A urinary concentration of free TMA of 10 &#x000b5;g/mL (18-20 &#x000b5;mol/mmol creatinine) or higher, correlating with a urinary output of TMA of ~15-20 mg/day, appears to represent a threshold for the presence of the fishy body odor associated with the disorder [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>].</div></li></ul><p>Click <a href="/books/NBK1103/bin/trimethylaminuria-TMAdetection.pdf">here</a> for more detailed information on specific methods of detecting TMA and TMA <i>N</i>-oxide in urine.</p></div><div id="trimethylaminuria.Establishing_the_Diagn"><h3>Establishing the Diagnosis</h3><p>The diagnosis of primary trimethylaminuria <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who:</p><ul><li class="half_rhythm"><div>Excretes (under normal dietary conditions) in the urine &#x0003e;10% of total trimethylamine (TMA) as the free amine; and</div></li><li class="half_rhythm"><div>Has <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> (<a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>), known <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants in FMO3 on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1103/table/trimethylaminuria.T.molecular_genetic_te/?report=objectonly" target="object" rid-figpopup="figtrimethylaminuriaTmoleculargeneticte" rid-ob="figobtrimethylaminuriaTmoleculargeneticte">Table 1</a>).</div></li></ul><p>Molecular testing includes <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FMO3</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</p><div id="trimethylaminuria.T.molecular_genetic_te" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Primary Trimethylaminuria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1103/table/trimethylaminuria.T.molecular_genetic_te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trimethylaminuria.T.molecular_genetic_te_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FMO3</i></td><td headers="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td></tr><tr><td headers="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_trimethylaminuria.T.molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="trimethylaminuria.TF.1.1"><p class="no_margin">See <a href="/books/NBK1103/#trimethylaminuria.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="trimethylaminuria.TF.1.2"><p class="no_margin">See <a href="#trimethylaminuria.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="trimethylaminuria.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="trimethylaminuria.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used can include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="trimethylaminuria.TF.1.5"><p class="no_margin">One individual with primary trimethylaminuria <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of exons 1 and 2 has been reported [<a class="bk_pop" href="#trimethylaminuria.REF.forrest.2001.169">Forrest et al 2001</a>]. To date, this is the only <i>FMO3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> reported to be a large deletion.</p></div></dd></dl></div></div></div></div></div><div id="trimethylaminuria.Clinical_Characteristi"><h2 id="_trimethylaminuria_Clinical_Characteristi_">Clinical Characteristics</h2><div id="trimethylaminuria.Clinical_Description"><h3>Clinical Description</h3><p>Primary trimethylaminuria is characterized by fishy odor resulting from excess excretion of trimethylamine in the urine, breath, sweat, and reproductive fluids [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mackay.2011.33">Mackay et al 2011</a>].</p><p>No physical symptoms are associated with primary trimethylaminuria; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals appear normal and healthy. However, the unpleasant odor characteristic of the disorder often results in social and psychological problems [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>] and can have serious effects on personal and working lives. These may include the following:</p><ul><li class="half_rhythm"><div>In childhood, being shunned, ridiculed, or bullied at school, leading to aggressive or disruptive behavior and poor educational performance</div></li><li class="half_rhythm"><div>A sense of shame or embarrassment, leading to low self-esteem and reluctance to seek medical help</div></li><li class="half_rhythm"><div>Avoidance of contact with people, leading to social isolation, loneliness, frustration, and depression</div></li><li class="half_rhythm"><div>Difficulties in initiating or maintaining relationships</div></li><li class="half_rhythm"><div>In extreme cases: paranoid behavior, desperation, and suicidal tendencies</div></li></ul><p>The enzyme FMO3 is also involved in the metabolism of various therapeutic drugs. Individuals with primary trimethylaminuria exhibit abnormal metabolism of the nonsteroidal anti-inflammatory benzydamine [<a class="bk_pop" href="#trimethylaminuria.REF.mayatepek.2004.775">Mayatepek et al 2004</a>]. Anecdotal evidence suggests that the metabolism of other drugs that are substrates of the enzyme FMO3 may also be affected.</p><p>Dysfunctional metabolism of endogenous amines such as tyramine that are substrates of the enzyme FMO3 may contribute to the depression seen in some persons.</p><p>For individuals with primary trimethylaminuria, symptoms are usually present from birth. The condition may worsen during puberty. In females, symptoms are more severe just before and during menstruation, after taking oral contraceptives, and around menopause, probably because of a decrease in expression of <i>FMO3</i> in response to steroid hormones.</p><p><a href="#trimethylaminuria.Management">Treatment and dietary management</a> may alleviate symptoms in some, but not all individuals.</p><p><b>Other.</b> Historical references to individuals who appear to have had trimethylaminuria include the description of Satyavati, a young woman who smelled of rotting fish, in the <i>Mahabharata</i>, the Indian epic of the Bharata Dynasty compiled in about AD 400, and Trinculo's description of Caliban ("he smells like a fish") in Shakespeare's <i>The Tempest</i>.</p></div><div id="trimethylaminuria.Pathophysiology"><h3>Pathophysiology</h3><p>Metabolism of trimethylamine is primarily via <i>N</i>-oxygenation, catalyzed by the enzyme flavin-containing monooxygenase 3 (FMO3) [<a class="bk_pop" href="#trimethylaminuria.REF.lang.1998.1005">Lang et al 1998</a>, <a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al 2003</a>, <a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>].</p><p>Trimethylamine is derived from dietary precursors, such as choline and trimethylamine <i>N</i>-oxide, via the action of bacteria in the gut [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mackay.2011.33">Mackay et al 2011</a>]. It is normally metabolized in the liver by the enzyme FMO3 to produce trimethylamine <i>N</i>-oxide, which is non-volatile and non-odorous [<a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al 2003</a>, <a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>]. Excess trimethylamine results from a mismatch between the ability of the enzyme FMO3 to catalyze the <i>N</i>-oxygenation of trimethylamine and the amount of substrate.</p><p>Two types of trimethylaminuria exist, resulting from one of the following:</p><ul><li class="half_rhythm"><div><b>Decrease in the amount or activity of the enzyme FMO3,</b> resulting from genetic factors (mutation of <i>FMO3</i>), physiologic factors (hormone levels), or environmental factors (presence of inhibitory chemicals). This type of trimethylaminuria is characterized by a high urinary TMA/TMA <i>N</i>-oxide ratio.</div></li><li class="half_rhythm"><div><b>Substrate overload of FMO3 enzyme activity</b> resulting from either an excess of dietary precursors of TMA or variations in gut flora, causing increased release of TMA. This type of trimethylaminuria is characterized by a high concentration of TMA in the urine, but a normal urinary TMA/TMA <i>N</i>-oxide ratio.</div></li></ul><p>The two types of trimethylaminuria are intimately interrelated: a combination of genetic, physiologic, and environmental factors may interact to give rise to the disorder. For instance, a substrate load that is handled by one individual may represent a substrate overload for a person whose FMO3 enzyme activity is decreased.</p></div><div id="trimethylaminuria.GenotypePhenotype_Corr"><h3>Genotype-Phenotype Correlations</h3><p>On a normal diet, individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>FMO3</i> pathogenic variants secrete more than 40% of total TMA as the free unmetabolized amine and consequently have a fishy odor.</p><p>Several pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that abolish or severely impair the ability of the FMO3 enzyme to catalyze <i>N</i>-oxygenation of TMA have been identified [<a class="bk_pop" href="#trimethylaminuria.REF.hernandez.2003.209">Hernandez et al 2003</a>, <a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>, <a class="bk_pop" href="#trimethylaminuria.REF.yamazaki.2013.1588">Yamazaki &#x00026; Shimizu 2013</a>]. In general, the more severe the reduction in FMO3 enzyme activity, the more severe the symptoms and the less the response to treatment.</p><p>While most common variants have little or no effect on enzyme activity, p.Glu158Lys and p.Glu308Gly in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration (i.e., on the same <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a>) have been associated with "mild" trimethylaminuria, resulting in the excretion of 10%-39% of total TMA as the free unmetabolized amine [<a class="bk_pop" href="#trimethylaminuria.REF.zschocke.1999.834">Zschocke et al 1999</a>].</p><p>Although the rare variant p.Val187Ala alone does not affect enzyme activity, a combination of this variant in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration with p.Glu158Lys severely affects enzyme activity and contributes to severe trimethylaminuria [<a class="bk_pop" href="#trimethylaminuria.REF.motika.2009.128">Motika et al 2009</a>].</p></div><div id="trimethylaminuria.Nomenclature"><h3>Nomenclature</h3><p>Primary trimethylaminuria has been described as fish-odor syndrome, fish malodor syndrome, and stale fish syndrome.</p></div><div id="trimethylaminuria.Prevalence"><h3>Prevalence</h3><p>The incidence of heterozygotes (carriers) in the white British population is 0.5% to 1.0%. It is higher in other populations studied: 1.7% in Jordan, 3.8% in Ecuador, and 11.0% in New Guinea [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.1997.45">Mitchell et al 1997</a>].</p></div></div><div id="trimethylaminuria.Genetically_Related_Al"><h2 id="_trimethylaminuria_Genetically_Related_Al_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>FMO3</i>.</p></div><div id="trimethylaminuria.Differential_Diagnosis"><h2 id="_trimethylaminuria_Differential_Diagnosis_">Differential Diagnosis</h2><p>Molecular diagnosis can distinguish primary trimethylaminuria from trimethylaminuria not caused by genetic FMO3 deficiency [<a class="bk_pop" href="#trimethylaminuria.REF.shimizu.2014.839">Shimizu et al 2014</a>]. A classification scheme for the latter has been proposed [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>].</p><ul><li class="half_rhythm"><div><b>Acquired trimethylaminuria</b> emerges during adult life as a consequence of hepatitis in individuals with no previous personal history or <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> history of the disorder. The metabolic changes persist after the liver problems have resolved, suggesting a permanent change in the expression or activity of the FMO3 enzyme.</div></li><li class="half_rhythm"><div><b>Transient childhood trimethylaminuria</b> has been reported in preterm infants fed a choline-containing infant formula. Symptoms disappear as the children mature or when the choline source is discontinued [<a class="bk_pop" href="#trimethylaminuria.REF.pardini.2003.101">Pardini &#x00026; Sapien 2003</a>]. Young children who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>FMO3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or have certain combinations of <i>FMO3</i> variants (see <a href="#trimethylaminuria.GenotypePhenotype_Corr">Genotype-Phenotype Correlations</a>) may exhibit mild symptoms of the disorder [<a class="bk_pop" href="#trimethylaminuria.REF.mayatepek.1998.1205">Mayatepek &#x00026; Kohlmuller 1998</a>, <a class="bk_pop" href="#trimethylaminuria.REF.zschocke.1999.834">Zschocke et al 1999</a>, <a class="bk_pop" href="#trimethylaminuria.REF.zschocke.2000.378">Zschocke &#x00026; Mayatepek 2000</a>]. Transient childhood forms are a consequence of the immaturity of <i>FMO3</i> expression, which is switched on after birth and continues to increase throughout childhood [<a class="bk_pop" href="#trimethylaminuria.REF.koukouritaki.2002.236">Koukouritaki et al 2002</a>].</div></li><li class="half_rhythm"><div><b>Transient trimethylaminuria associated with menstruation.</b> A short episode of trimethylaminuria can occur in women during menstruation [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>, <a class="bk_pop" href="#trimethylaminuria.REF.shimizu.2007.2">Shimizu et al 2007</a>]. The effect is more pronounced in women <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for variants that result in a mild decrease in FMO3 enzyme activity [<a class="bk_pop" href="#trimethylaminuria.REF.shimizu.2007.2">Shimizu et al 2007</a>].</div></li><li class="half_rhythm"><div><b>Precursor overload</b> can cause a transient form of trimethylaminuria that results from saturation of the enzyme FMO3. It can occur in individuals with <a href="/books/n/gene/huntington/">Huntington disease</a> or <a href="/books/n/gene/alzheimer/">Alzheimer disease</a> who have been given large oral therapeutic doses of choline (&#x02264;20 g/day) [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2001.517">Mitchell &#x00026; Smith 2001</a>, <a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>].</div></li><li class="half_rhythm"><div><b>Disease states</b></div><ul><li class="half_rhythm"><div>Liver cirrhosis, impaired hepatocellular function, or the existence of portosystemic shunts may affect clearance of TMA absorbed from the gut. The resulting trimethylaminuria may contribute to the development of hepatic encephalopathy and coma and associated foetor hepaticus [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.1999.524">Mitchell et al 1999</a>].</div></li><li class="half_rhythm"><div>In uremia, increased release of TMA from dietary precursors as a consequence of bacterial overgrowth in the small intestine, coupled with reduced renal clearance of TMA, can result in trimethylaminuria [<a class="bk_pop" href="#trimethylaminuria.REF.mitchell.2005.10">Mitchell 2005</a>]. The elevated blood concentration of TMA may contribute to nephritic neurologic conditions.</div></li></ul></li></ul><p>Other causes of unpleasant body odor fall into two categories:</p><ul><li class="half_rhythm"><div><b>Those not involving an increase of trimethylamine in the urine,</b> including poor hygiene, gingivitis, and cases of blood-borne halitosis [<a class="bk_pop" href="#trimethylaminuria.REF.tangerman.2002.201">Tangerman 2002</a>] resulting from malodorous compounds other than trimethylamine. Another condition in this category is the rare metabolic disorder dimethylglycinuria, caused by dimethylglycine dehydrogenase deficiency [<a class="bk_pop" href="#trimethylaminuria.REF.binzak.2001.839">Binzak et al 2001</a>]. Such conditions are distinguished by low urinary TMA and a normal urinary TMA/TMA <i>N</i>-oxide ratio.</div></li><li class="half_rhythm"><div><b>Those resulting in an increase of trimethylamine in the urine,</b> including urinary tract infections, bacterial vaginosis, advanced liver or kidney disease, and cervical cancer. In these cases, the TMA/TMA <i>N</i>-oxide ratio is normal, but <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have large amounts of TMA in the urine. In contrast, primary trimethylaminuria, caused by FMO3 deficiency, is characterized by a high ratio of TMA/TMA <i>N</i>-oxide in the urine.</div></li></ul></div><div id="trimethylaminuria.Management"><h2 id="_trimethylaminuria_Management_">Management</h2><div id="trimethylaminuria.Evaluations_Following"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with primary trimethylaminuria, it is recommended that the urinary ratio of trimethylamine (TMA) <i>N</i>-oxide to total TMA on a normal diet be determined. The general rule is that the lower the ratio the more severe the disorder:</p><ul><li class="half_rhythm"><div>Ratios of 70%-89% are classified as mild.</div></li><li class="half_rhythm"><div>Ratios lower than 70% are classified as severe.</div></li></ul><p>Consultation with a clinical geneticist and/or genetic counselor is also recommended.</p></div><div id="trimethylaminuria.Treatment_of_Manifesta"><h3>Treatment of Manifestations</h3><p>Strategies for the treatment of primary trimethylaminuria summarized below are covered in detail in <a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al [2003]</a> and in "best-practice" guidelines [<a class="bk_pop" href="#trimethylaminuria.REF.chalmers.2006">Chalmers et al 2006</a>].</p><p><b>Restriction of dietary trimethylamine and its precursors.</b> In some instances the disorder can be successfully managed by dietary restriction of precursors of trimethylamine. This is particularly true of "mild" or moderate forms of primary trimethylaminuria. Affected individuals respond differently to different forms of dietary restriction; thus, urinary excretion of trimethylamine and trimethylamine <i>N</i>-oxide should be monitored to identify the most effective dietary regimen for an individual.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Choline.</b> One of the most important dietary sources of trimethylamine is choline. Dietary choline is absorbed through the small intestine; however, when the absorptive capacity of the small intestine is overloaded, gut bacteria metabolize choline into trimethylamine, which is readily absorbed into the blood stream.</div><div class="half_rhythm">Foods rich in choline include eggs, liver, kidney, peas, beans, peanuts, soya products, and brassicas (Brussels sprouts, broccoli, cabbage, cauliflower) as well as rapeseed products such as oil and flour. Nutritionally balanced, choline-restricted diets suitable for the treatment of trimethylaminuria have been developed [<a class="bk_pop" href="#trimethylaminuria.REF.busby.2004.1836">Busby et al 2004</a>].</div><div class="half_rhythm">Affected individuals should avoid lecithin (an important dietary source of choline) and lecithin-containing fish oil supplements.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Trimethylamine <i>N</i>-oxide.</b> Affected individuals should avoid eating seafood (fish, cephalopods, and crustaceans) because of its high content of trimethylamine <i>N</i>-oxide, which is reduced to trimethylamine in the human gut. Babies with trimethylaminuria who are breastfed after their mothers have eaten seafood may develop a fishy odor.</div><div class="half_rhythm">Note: Freshwater fish have a lower content of trimethylamine <i>N</i>-oxide and thus are not a problem.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Other.</b> Milk obtained from wheat-fed cows may have significant amounts of trimethylamine and thus should be avoided.</div><div class="half_rhythm">In addition to being a source of trimethylamine precursors, brassicas (Brussels sprouts, broccoli, cabbage, and cauliflower) contain indoles, which may inhibit FMO3 enzyme activity and thus increase urinary excretion of trimethylamine [<a class="bk_pop" href="#trimethylaminuria.REF.cashman.1999.1047">Cashman et al 1999</a>]. Intake of such vegetables should be restricted.</div></li></ul><p><b>Use of acid soaps and body lotions.</b> Trimethylamine is a strong base (pKa 9.8). Thus, at pH 6.0, less than 0.02% of trimethylamine exists as the volatile free base. The use of soaps and body lotions with a pH close to that of normal skin (pH 5.5-6.5) helps retain secreted trimethylamine in a less volatile salt form that can be removed by washing.</p><p><b>Sequestering of trimethylamine produced in the gut.</b> When taken as dietary supplements, activated charcoal (750 mg 2x/day for 10 days) and copper chlorophyllin (60 mg 3x/day after meals for 3 weeks) decrease the concentration of free trimethylamine in the urine [<a class="bk_pop" href="#trimethylaminuria.REF.yamazaki.2004.2739">Yamazaki et al 2004</a>].</p><p><b>Suppression of intestinal production of trimethylamine.</b> A short course of antibiotics to modulate or reduce the activity of gut microflora, and thus suppress the production of trimethylamine, is effective in some cases [<a class="bk_pop" href="#trimethylaminuria.REF.fraserandrews.2003.203">Fraser-Andrews et al 2003</a>, <a class="bk_pop" href="#trimethylaminuria.REF.chalmers.2006">Chalmers et al 2006</a>]. Such treatment may be useful when dietary restriction needs to be relaxed (e.g., for important social occasions), or when trimethylamine production appears to increase (e.g., during menstruation, infection, emotional upset, stress, or exercise). Three antibiotics with different target organisms have been used: metronidazole, amoxicillin, and neomycin. Neomycin appears to be the most effective in preventing formation of trimethylamine from choline [<a class="bk_pop" href="#trimethylaminuria.REF.chalmers.2006">Chalmers et al 2006</a>].</p><p><b>Enhancement of residual FMO3 enzyme activity.</b> Supplements of riboflavin, a precursor of the FAD prosthetic group of FMOs, may help maximize residual FMO3 enzyme activity [<a class="bk_pop" href="#trimethylaminuria.REF.manning.2012.71">Manning et al 2012</a>]. Recommended intake is 30-40 mg 3-5x/day with food. Children given riboflavin should be monitored closely because excessive amounts may cause gastrointestinal distress.</p><p><b>Counseling.</b> Affected individuals and their families benefit from counseling. Realization that the problem is the result of a recognized medical condition may help. As well as receiving dietary advice, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be advised that the condition may be exacerbated during menstruation and by factors that promote sweating, such as fever, exercise, stress, and emotional upsets.</p></div><div id="trimethylaminuria.Prevention_of_Primary"><h3>Prevention of Primary Manifestations</h3><p>See <a href="#trimethylaminuria.Treatment_of_Manifesta">Treatment of Manifestations</a>.</p></div><div id="trimethylaminuria.Prevention_of_Secondar"><h3>Prevention of Secondary Complications</h3><p>Because choline is essential in the fetus and in young infants for nerve and brain development, it should not be over-restricted in infants, children, and pregnant or lactating women. Large amounts of choline are transferred to the fetus via the placenta and to the newborn infant via the mother's milk, thus potentially depleting maternal choline reserves. Dietary restriction of choline increases the requirement for folate, a methyl donor.</p><p>Dietary regimens should be planned and monitored to ensure that the daily intake of choline and folate meet recommendations for the age and sex of the individual [<a class="bk_pop" href="#trimethylaminuria.REF13">Institute of Medicine National Academy of Sciences USA 1998</a>, <a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al 2003</a>]. For adults, adequate daily intake of choline is 550 mg for males and 425 mg for females.</p></div><div id="trimethylaminuria.AgentsCircumstances_to"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Foods with a high content of precursors of trimethylamine or inhibitors of FMO3 enzyme activity, including seafood (fish, cephalopods, and crustaceans), eggs, offal, legumes, brassicas, and soya products; avoid or eat in moderation.</div></li><li class="half_rhythm"><div>Food supplements and "health" foods that contain high doses of the trimethylamine precursors choline and lecithin</div></li><li class="half_rhythm"><div>Drugs that are metabolized by the FMO3 enzyme; for example, the antipsychotic clozapine; the monoamine oxidase B inhibitor deprenyl; the anti-histamine ranitidine; the anti-estrogen tamoxifen; and the nonsteroidal anti-inflammatories benzydamine and sulindac [<a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>]. These compete for residual FMO3 activity. As well as exacerbating the condition, reduced metabolism of the drug may cause adverse effects.</div></li><li class="half_rhythm"><div>Factors that promote sweating (e.g., exercise, stress, emotional upsets)</div></li></ul></div><div id="trimethylaminuria.Evaluation_of_Relative"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from early <a href="#trimethylaminuria.Treatment_of_Manifesta">treatment of manifestations</a>. Evaluations can include:</p><ul><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing if the <i>FMO3</i> pathogenic variants in the family are known;</div><div class="half_rhythm">If the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>FMO3</i> pathogenic variants are not known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> may detect pathogenic variants.</div></li><li class="half_rhythm"><div class="half_rhythm">Biochemical testing if the <i>FMO3</i> pathogenic variants in the family are not known and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> fails to reveal a well-known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p>See <a href="#trimethylaminuria.Related_Genetic_Counse">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="trimethylaminuria.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Choline, which is essential for nerve and brain development in the fetus, should not be over-restricted in pregnant women.</p></div><div id="trimethylaminuria.Therapies_Under_Invest"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="trimethylaminuria.Genetic_Counseling"><h2 id="_trimethylaminuria_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="trimethylaminuria.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Primary trimethylaminuria is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="trimethylaminuria.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>FMO3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with primary trimethylaminuria are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FMO3</i>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>FMO3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="trimethylaminuria.Carrier_Heterozygote_D"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>FMO3</i> pathogenic variants in the family.</p><p><b>Biochemical genetic testing.</b> Under normal dietary conditions heterozygotes (carriers) and unaffected individuals excrete less than 10% of total trimethylamine (TMA) as the unmetabolized free amine and thus cannot be distinguished [<a class="bk_pop" href="#trimethylaminuria.REF.cashman.2003.151">Cashman et al 2003</a>]; thus, carriers are best identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div id="trimethylaminuria.Related_Genetic_Counse"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#trimethylaminuria.Evaluation_of_Relative">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="trimethylaminuria.Prenatal_Testing_and_P"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FMO3</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for primary trimethylaminuria are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="trimethylaminuria.Resources"><h2 id="_trimethylaminuria_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Human Genome Research Institute (NHGRI)</b></div><div><a href="http://www.genome.gov/11508983" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Learning About Trimethylaminuria</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=trimethylaminuria" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trimethylaminuria</a></div></li><li class="half_rhythm"><div><b>Trimethylaminuria Foundation</b></div><div>Grand Central Station</div><div>PO Box 3361</div><div>New York NY 10163-3361</div><div><b>Phone:</b> 212-300-4168</div><div><b>Email:</b> thetfnetwk@aol.com</div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="trimethylaminuria.Molecular_Genetics"><h2 id="_trimethylaminuria_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="trimethylaminuria.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Primary Trimethylaminuria: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1103/table/trimethylaminuria.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trimethylaminuria.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_trimethylaminuria.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_trimethylaminuria.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_trimethylaminuria.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_trimethylaminuria.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_trimethylaminuria.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_trimethylaminuria.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_trimethylaminuria.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2328" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FMO3</i></a></td><td headers="hd_b_trimethylaminuria.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2328" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_trimethylaminuria.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P31513" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dimethylaniline monooxygenase [N-oxide-forming] 3</a></td><td headers="hd_b_trimethylaminuria.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FMO3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FMO3 database</a></td><td headers="hd_b_trimethylaminuria.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FMO3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FMO3</a></td><td headers="hd_b_trimethylaminuria.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FMO3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FMO3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="trimethylaminuria.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="trimethylaminuria.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Primary Trimethylaminuria (<a href="/omim/136132,602079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1103/table/trimethylaminuria.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trimethylaminuria.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/136132" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">136132</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FLAVIN-CONTAINING MONOOXYGENASE 3; FMO3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602079" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602079</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRIMETHYLAMINURIA; TMAU</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>FMO3</i> spans 27 kb and contains nine exons; <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 is non-coding [<a class="bk_pop" href="#trimethylaminuria.REF.dolphin.1997b.260">Dolphin et al 1997b</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encodes a mature <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> of 2.1 kb. For a detailed summary of gene and protein information, see <a href="/books/NBK1103/#trimethylaminuria.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Fifteen different nonsynonymous single-nucleotide variants have been identified [<a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>] (see <a href="http://databases.lovd.nl/shared/genes/FMO3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>FMO3</i> Database</a>). Individually, with the exception of p.Asn61Lys and p.Leu360Pro, these have little or no effect on protein function. However, some nonsynonymous variants when present in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state can cause a "mild" <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b>Pathogenic variants.</b> More than 30 distinct pathogenic variants have been reported [<a class="bk_pop" href="#trimethylaminuria.REF.hernandez.2003.209">Hernandez et al 2003</a>, <a class="bk_pop" href="#trimethylaminuria.REF.yamazaki.2013.1588">Yamazaki &#x00026; Shimizu 2013</a>] (see <a href="http://databases.lovd.nl/shared/genes/FMO3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>FMO3</i> Database</a> and <a href="/books/NBK1103/bin/trimethylaminuria-Table3.pdf">Table 3</a> [pdf]). Most are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, but <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, small (1- or 2-bp) deletions, and one large (12.2-kb) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have been reported.</p><p>The most common pathogenic variants identified to date are p.Pro153Leu [<a class="bk_pop" href="#trimethylaminuria.REF.dolphin.1997a.491">Dolphin et al 1997a</a>] and p.Glu305Ter [<a class="bk_pop" href="#trimethylaminuria.REF.treacy.1998.839">Treacy et al 1998</a>].</p><p>Some nonsynonymous variants, when present in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration (e.g., p.Glu158Lys and p.Glu308Gly) result in moderately decreased enzyme activity [<a class="bk_pop" href="#trimethylaminuria.REF.koukouritaki.2005.807">Koukouritaki &#x00026; Hines 2005</a>, <a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>]. In the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state (i.e., p.Glu158Lys and p.Glu308Gly present in <i>cis</i> configuration on both chromosomes), they may cause mild or transient primary trimethylaminuria, particularly in infants and young children [<a class="bk_pop" href="#trimethylaminuria.REF.zschocke.1999.834">Zschocke et al 1999</a>, <a class="bk_pop" href="#trimethylaminuria.REF.zschocke.2000.378">Zschocke &#x00026; Mayatepek 2000</a>], who have low expression of <i>FMO3</i> [<a class="bk_pop" href="#trimethylaminuria.REF.koukouritaki.2002.236">Koukouritaki et al 2002</a>].</p><p>The variant p.Val187Ala alone does not affect enzyme activity, but p.Val187Ala in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration with p.Glu158Lys has a severe effect on enzyme activity [<a class="bk_pop" href="#trimethylaminuria.REF.motika.2009.128">Motika et al 2009</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Asn61Ser abolishes <i>N</i>-oxygenation of trimethylamine and thus causes trimethylaminuria but has no effect on the <i>S</i>-oxygenation of methimazole [<a class="bk_pop" href="#trimethylaminuria.REF.dolphin.2000.799">Dolphin et al 2000</a>].</p><p>The p.Leu360Pro variant is the only variant known to result in an increase in enzyme activity [<a class="bk_pop" href="#trimethylaminuria.REF.lattard.2003.854">Lattard et al 2003</a>].</p><p>When novel variants are identified, it is important to establish that they (1) cosegregate with the disorder in the family and (2) abolish or substantially reduce the ability to catalyze <i>N</i>-oxygenation of TMA as assessed by assaying heterologously expressed variant protein.</p><div id="trimethylaminuria.T.selected_fmo3_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>FMO3</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1103/table/trimethylaminuria.T.selected_fmo3_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trimethylaminuria.T.selected_fmo3_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>"Mild" variants that affect enzyme activity&#x000a0;<sup>1</sup></b></td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[472G&#x0003e;A;923A&#x0003e;G]</td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.[Glu158Lys;Glu308Gly]</td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_4" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=50541964" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006894<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_008825.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_008825<wbr style="display:inline-block"></wbr>​.4</a></td></tr><tr><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Increased enzyme activity</b></td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1079T&#x0003e;C</td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu360Pro</td></tr><tr><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.182A&#x0003e;G</td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn61Ser</td></tr><tr><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.458C&#x0003e;T</td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro153Leu</td></tr><tr><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.[472G&#x0003e;A;560T&#x0003e;C]&#x000a0;<sup>2</sup></td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.[Glu158Lys;Val187Ala]&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.913G&#x0003e;T</td><td headers="hd_h_trimethylaminuria.T.selected_fmo3_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu305Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="trimethylaminuria.TF.2.1"><p class="no_margin">See details in discussion preceding table.</p></div></dd><dt>2. </dt><dd><div id="trimethylaminuria.TF.2.2"><p class="no_margin">Denotes two changes in one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal product of <i>FMO3</i> is the protein flavin-containing monooxygenase 3 (FMO3), which has a molecular mass of 60 kd and contains 532 amino acid residues [<a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>]. FMO3 is located in the membranes of the endoplasmic reticulum. The enzyme catalyzes the oxygenation of a wide range of foreign chemicals. At the site of oxygenation preferred substrates contain a soft nucleophile &#x02013; typically a nitrogen, sulfur, phosphorous, or selenium atom [<a class="bk_pop" href="#trimethylaminuria.REF.krueger.2005.357">Krueger &#x00026; Williams 2005</a>]. One of the reactions catalyzed by FMO3 is the oxygenation of the odorous tertiary amine trimethylamine to its non-odorous <i>N</i>-oxide.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenic variants that cause severe trimethylaminuria essentially abolish FMO3 activity and are thus "<a class="def" href="/books/n/gene/glossary/def-item/null/">null</a>" variants [<a class="bk_pop" href="#trimethylaminuria.REF.phillips.2007.292">Phillips et al 2007</a>].</p><p>Some pathogenic variants impair assembly of the holoenzyme (i.e., the ability of the apoprotein to bind FAD) whereas others affect kinetic competency [<a class="bk_pop" href="#trimethylaminuria.REF.yeung.2007.251">Yeung et al 2007</a>].</p></div><div id="trimethylaminuria.References"><h2 id="_trimethylaminuria_References_">References</h2><div id="trimethylaminuria.Published_Guidelines"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.chalmers.2006">Chalmers RA, Bain MD, Michelakakis H, Zschocke J, Iles RA. Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. 2006. [<a href="/pubmed/16601883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16601883</span></a>]</div></li></ul></div><div id="trimethylaminuria.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.binzak.2001.839">Binzak BA, Wevers RA, Moolenaar SH, Lee YM, Hwu WL, Poggi-Bach J, Engelke UF, Hoard HM, Vockley JG, Vockley J. Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:839–47.</span> [<a href="/pmc/articles/PMC1275637/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1275637</span></a>] [<a href="/pubmed/11231903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11231903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.busby.2004.1836">Busby MG, Fischer L, da Costa KA, Thompson D, Mar MH, Zeisel SH. Cho. <span><span class="ref-journal">J Am Diet Assoc. </span>2004;<span class="ref-vol">104</span>:1836–45.</span> [<a href="/pubmed/15565078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15565078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.cashman.2003.151">Cashman JR, Camp K, Fakharzadeh SS, Fennessey PV, Hines RN, Mamer OA, Mitchell SC, Nguyen GP, Schlenk D, Smith RL, Tjoa SS, Williams DE, Yannicelli S. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. <span><span class="ref-journal">Curr Drug Metab. </span>2003;<span class="ref-vol">4</span>:151–70.</span> [<a href="/pubmed/12678693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12678693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.cashman.1999.1047">Cashman JR, Xiong Y, Lin J, Verhagen H, van Poppel G, van Bladeren PJ, Larsen-Su S, Williams DE. In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. <span><span class="ref-journal">Biochem Pharmacol. </span>1999;<span class="ref-vol">58</span>:1047–55.</span> [<a href="/pubmed/10509757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10509757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.chalmers.2006.162">Chalmers RA, Bain MD, Michelakakis H, Zschocke J, Iles RA. Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. <span><span class="ref-journal">J Inherit Metab Dis. </span>2006;<span class="ref-vol">29</span>:162–72.</span> [<a href="/pubmed/16601883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16601883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.dolphin.1997a.491">Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. <span><span class="ref-journal">Nat Genet. </span>1997a;<span class="ref-vol">17</span>:491–4.</span> [<a href="/pubmed/9398858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9398858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.dolphin.2000.799">Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR. Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome. <span><span class="ref-journal">Pharmacogenetics. </span>2000;<span class="ref-vol">10</span>:799–807.</span> [<a href="/pubmed/11191884" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11191884</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.dolphin.1997b.260">Dolphin CT, Riley JH, Smith RL, Shephard EA, Phillips IR. Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA. <span><span class="ref-journal">Genomics. </span>1997b;<span class="ref-vol">46</span>:260–7.</span> [<a href="/pubmed/9417913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9417913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.forrest.2001.169">Forrest SM, Knight M, Akerman BR, Cashman JR, Treacy EP. A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria. <span><span class="ref-journal">Pharmacogenetics. </span>2001;<span class="ref-vol">11</span>:169–74.</span> [<a href="/pubmed/11266081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11266081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.fraserandrews.2003.203">Fraser-Andrews EA, Manning NJ, Ashton GH, Eldridge P, McGrath J, Menage Hdu P. Fish odour syndrome with features of both primary and secondary trimethylaminuria. <span><span class="ref-journal">Clin Exp Dermatol. </span>2003;<span class="ref-vol">28</span>:203–5.</span> [<a href="/pubmed/12653714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12653714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.hernandez.2003.209">Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR. Trimethylaminuria and a human FMO3 mutation database. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">22</span>:209–13.</span> [<a href="/pubmed/12938085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12938085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF13">Institute of Medicine National Academy of Sciences USA. <em>Dietary Reference Intakes for Folate, Thiamin, Riboflavin, Niacin, Vitamin B<sub>12</sub>, Pantothenic Acid, Biotin, and Choline.</em> Washington, DC: National Academy Press; 1998.</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.koukouritaki.2005.807">Koukouritaki SB, Hines RN. Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development. <span><span class="ref-journal">Pharmacogenomics. </span>2005;<span class="ref-vol">6</span>:807–22.</span> [<a href="/pubmed/16296944" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16296944</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.koukouritaki.2002.236">Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expession. <span><span class="ref-journal">Pediatr Res. </span>2002;<span class="ref-vol">51</span>:236–43.</span> [<a href="/pubmed/11809920" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11809920</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.krueger.2005.357">Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. <span><span class="ref-journal">Pharmacol Ther. </span>2005;<span class="ref-vol">106</span>:357–87.</span> [<a href="/pmc/articles/PMC1828602/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1828602</span></a>] [<a href="/pubmed/15922018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15922018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.lang.1998.1005">Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki K, Philpot RM, Rettie AE. Isoform specificity of trimethylamine <em>N</em>-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. <span><span class="ref-journal">Biochem Pharmacol. </span>1998;<span class="ref-vol">56</span>:1005–12.</span> [<a href="/pubmed/9776311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9776311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.lattard.2003.854">Lattard V, Zhang J, Tran Q, Furnes B, Schlenk D, Cashman JR. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. <span><span class="ref-journal">Drug Metab Dispos. </span>2003;<span class="ref-vol">31</span>:854–60.</span> [<a href="/pubmed/12814961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12814961</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mackay.2011.33">Mackay RJ, McEntyre CJ, Henderson C, Lever M, George PM. Trimethylaminuria: causes and diagnosis of a socially distressing condition. <span><span class="ref-journal">Clin Biochem Rev. </span>2011;<span class="ref-vol">32</span>:33–43.</span> [<a href="/pmc/articles/PMC3052392/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3052392</span></a>] [<a href="/pubmed/21451776" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21451776</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.manning.2012.71">Manning NJ, Allen EK, Kirk RJ, Sharrard MJ, Smith EJ. Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy. <span><span class="ref-journal">JIMD Rep. </span>2012;<span class="ref-vol">5</span>:71–5.</span> [<a href="/pmc/articles/PMC3509925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3509925</span></a>] [<a href="/pubmed/23430919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mayatepek.2004.775">Mayatepek E, Flock B, Zschocke J. Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3. <span><span class="ref-journal">Pharmacogenetics. </span>2004;<span class="ref-vol">14</span>:775–7.</span> [<a href="/pubmed/15564885" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15564885</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mayatepek.1998.1205">Mayatepek E, Kohlmuller D. Transient trimethylaminuria in childhood. <span><span class="ref-journal">Acta Paediatr. </span>1998;<span class="ref-vol">87</span>:1205–7.</span> [<a href="/pubmed/9846928" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9846928</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mitchell.2005.10">Mitchell SC. Trimethylaminuria (fish-odour syndrome) and oral malodour. <span><span class="ref-journal">Oral Dis. </span>2005;<span class="ref-vol">11</span> Suppl 1:10–3.</span> [<a href="/pubmed/15752091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15752091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mitchell.1999.524">Mitchell S, Ayesh R, Barrett T, Smith R. Trimethylamine and foetor hepaticus. <span><span class="ref-journal">Scand J Gastroenterol. </span>1999;<span class="ref-vol">34</span>:524–8.</span> [<a href="/pubmed/10423071" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10423071</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mitchell.2001.517">Mitchell SC, Smith RL. Trimethylaminuria: the fish malodor syndrome. <span><span class="ref-journal">Drug Metab Dispos. </span>2001;<span class="ref-vol">29</span>:517–21.</span> [<a href="/pubmed/11259343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11259343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.mitchell.1997.45">Mitchell SC, Zhang AQ, Barrett T, Ayesh R, Smith RL. Studies on the discontinuous N-oxidation of trimethylamine among Jordanian, Ecuadorian and New Guinean populations. <span><span class="ref-journal">Pharmacogenetics. </span>1997;<span class="ref-vol">7</span>:45–50.</span> [<a href="/pubmed/9110361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9110361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.motika.2009.128">Motika MS, Zhang J, Zheng X, Riedler K, Cashman JR. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">97</span>:128–35.</span> [<a href="/pmc/articles/PMC2739593/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2739593</span></a>] [<a href="/pubmed/19321370" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19321370</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.pardini.2003.101">Pardini RS, Sapien RE. Trimethylaminuria (fish odor syndrome) related to the choline concentration of infant formula. <span><span class="ref-journal">Pediatr Emerg Care. </span>2003;<span class="ref-vol">19</span>:101–3.</span> [<a href="/pubmed/12698036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12698036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.phillips.2007.292">Phillips IR, Francois AA, Shephard EA. The flavin-containing monooxygenases (FMOs): genetic variation and its consequences for the metabolism of therapeutic drugs. <span><span class="ref-journal">Curr Pharmacogenet Pharmacogenom. </span>2007;<span class="ref-vol">5</span>:292–313.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.shephard.2015">Shephard EA, Treacy EP, Phillips IR. Clinical utility gene card for: Trimethylaminuria &#x02013; update 2014. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>(9)</span> [<a href="/pmc/articles/PMC4538216/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4538216</span></a>] [<a href="/pubmed/25335494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25335494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.shimizu.2014.839">Shimizu M, Allerston CK, Shephard EA, Yamazaki H, Phillips IR. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2014;<span class="ref-vol">77</span>:839–51.</span> [<a href="/pmc/articles/PMC4004404/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4004404</span></a>] [<a href="/pubmed/24028545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24028545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.shimizu.2007.2">Shimizu M, Cashman JR, Yamazaki H. Transient trimethylaminuria related to menstruation. <span><span class="ref-journal">BMC Med Genet. </span>2007;<span class="ref-vol">8</span>:2.</span> [<a href="/pmc/articles/PMC1790885/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1790885</span></a>] [<a href="/pubmed/17257434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17257434</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.tangerman.2002.201">Tangerman A. Halitosis in medicine: a review. <span><span class="ref-journal">Int Dent J. </span>2002;<span class="ref-vol">52</span> Suppl 3:201–6.</span> [<a href="/pubmed/12090453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12090453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.treacy.1998.839">Treacy EP, Akerman BR, Chow LM, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, Forrest SM. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:839–45.</span> [<a href="/pubmed/9536088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9536088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.yamazaki.2004.2739">Yamazaki H, Fujieda M, Togashi M, Saito T, Preti G, Cashman JR, Kamataki T. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. <span><span class="ref-journal">Life Sci. </span>2004;<span class="ref-vol">74</span>:2739–47.</span> [<a href="/pubmed/15043988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15043988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.yamazaki.2013.1588">Yamazaki H, Shimizu M. Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities. <span><span class="ref-journal">Biochem Pharmacol. </span>2013;<span class="ref-vol">85</span>:1588–93.</span> [<a href="/pubmed/23567996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23567996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.yeung.2007.251">Yeung CK, Adman ET, Rettie AE. Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria. <span><span class="ref-journal">Arch Biochem Biophys. </span>2007;<span class="ref-vol">464</span>:251–9.</span> [<a href="/pmc/articles/PMC2039921/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2039921</span></a>] [<a href="/pubmed/17531949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17531949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.zschocke.1999.834">Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E. Mild trimethylaminuria caused by common variants in FMO3 gene. <span><span class="ref-journal">Lancet. </span>1999;<span class="ref-vol">354</span>:834–5.</span> [<a href="/pubmed/10485731" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10485731</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.zschocke.2000.378">Zschocke J, Mayatepek E. Biochemical and molecular studies in mild flavin monooxygenase 3 deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span>:378–82.</span> [<a href="/pubmed/10896299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10896299</span></a>]</div></li></ul></div><div id="trimethylaminuria.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.phillips.2008.294">Phillips IR, Shephard EA. Flavin-containing monoxygenases: mutations, disease and drug response. <span><span class="ref-journal">Trends Pharmacol Sci. </span>2008;<span class="ref-vol">29</span>:294–301.</span> [<a href="/pubmed/18423897" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18423897</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trimethylaminuria.REF.treacy">Treacy EP. Trimethylaminuria and deficiency of flavin-containing monooxygenase type 3 (FMO3). In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <em>The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</em> Chap 88.1. McGraw-Hill.</div></li></ul></div></div><div id="trimethylaminuria.Chapter_Notes"><h2 id="_trimethylaminuria_Chapter_Notes_">Chapter Notes</h2><div id="trimethylaminuria.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 October 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 April 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 March 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically</div></li><li class="half_rhythm"><div>8 October 2007 (me) Review posted to live Web site</div></li><li class="half_rhythm"><div>30 July 2007 (eas) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1103</span><span class="label">PMID: <a href="/pubmed/20301282" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301282</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ph3/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lafora/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1103&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1103/?report=reader">PubReader</a></li><li><a href="/books/NBK1103/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1103" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1103" style="display:none" title="Cite this Page"><div class="bk_tt">Phillips IR, Shephard EA. Primary Trimethylaminuria. 2007 Oct 8 [Updated 2015 Oct 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1103/pdf/Bookshelf_NBK1103.pdf">PDF version of this page</a> (445K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#trimethylaminuria.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#trimethylaminuria.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#trimethylaminuria.Clinical_Characteristi" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#trimethylaminuria.Genetically_Related_Al" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#trimethylaminuria.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#trimethylaminuria.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#trimethylaminuria.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#trimethylaminuria.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#trimethylaminuria.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#trimethylaminuria.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#trimethylaminuria.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2328[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FMO3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1103+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1479102" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1479102" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1479102" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1479102" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16601883" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.</a><span class="source">[J Inherit Metab Dis. 2006]</span><div class="brieflinkpop offscreen_noflow">Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chalmers RA, Bain MD, Michelakakis H, Zschocke J, Iles RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Inherit Metab Dis. 2006 Feb; 29(1):162-72. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/9282831" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.</a><span class="source">[Chem Res Toxicol. 1997]</span><div class="brieflinkpop offscreen_noflow">Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cashman JR, Bi YA, Lin J, Youil R, Knight M, Forrest S, Treacy E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Chem Res Toxicol. 1997 Aug; 10(8):837-41. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17584019" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients.</a><span class="source">[Curr Drug Metab. 2007]</span><div class="brieflinkpop offscreen_noflow">Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yamazaki H, Shimizu M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Drug Metab. 2007 Jun; 8(5):487-91. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301700" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bennett MJ, Santani AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301282" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301282" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040dc975f66d18aa9e8679">Primary Trimethylaminuria - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Primary Trimethylaminuria - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:32:57-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C6712E03F69610000000008A102E3&amp;ncbi_session=CE8C6712E040DC81_2209SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1103%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1103&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1103/&amp;ncbi_pagename=Primary Trimethylaminuria - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6712E040DC81_2209SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>